tm logo
ALYFTREK
FORMALIZED

on 14 Feb 2024

Last Applicant/ Owned by

VERTEX PHARMACEUTICALS INCORPORATED

50 Northern AvenueBoston MA 02210

US

Serial Number

2310673 filed on 17th Jan 2024

ALYFTREK

Trademark usage description

pharmaceutical preparations for the treatment of cystic fibrosis.

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cystic fibrosis.


Classification kind code

12

Mark Details


Serial Number

2310673

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 15th Feb 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 14th Feb 2024
Created
Submitted for opposition 31
on 14th Feb 2024
Formalized
Submitted for opposition 228
on 17th Jan 2024
International Registration
Submitted for opposition 30
on 17th Jan 2024
Filed